Figure 3.

Combinatorial effect of kaempferol with sorafenib on cell viability in human liver cancer cells, HepG2 and murine liver cancer cells, N1S1: HepG2 cells were treated with kaempferol and sorafenib individually for 72 h and cell viability was assessed by MTT assay as described under “Experimental Procedures.” (A)In HepG2, a combination of 2.5µM sorafenib and 2.5µM kaempferol showed 50% inhibition of cancerous cells with co-incubation of both. (B) In N1S1, a combination of 2.5µM sorafenib and 2.5µM kaempferol showed 50% inhibition of cancerous cells with co-incubation of both.